Richard Torbett outlines the case for investing in our sector ahead of the autumn's Comprehensive Spending Review.
The Department of Health Northern Ireland has launched a consultation for a 10-year strategy to tackle cancer.
NICE is launching its final consultation on proposed changes to the way it develops recommendations across its health technology evaluation programmes.
On International Clinical Trials Day, Colette Goldrick explains our call for the new Health and Care Bill to ensure NHS organisations conduct and resource clinical research.
The government has published its vision for the future of clinical research, setting out how it intends to capitalise on the successes of the past year.
ABPI President Haseeb Ahmad says that genome sequencing and advanced therapies give hope to people with rare diseases and their families – we have to get them into the hands of patients.
Nicola Redfern, General Manager of bluebird bio in the UK, describes the commercial challenges for rare disease medicines in the UK and reflects on the opportunities of gene therapies.
Dr Lucy McKay, CEO of the charity Medics4Rare Diseases tells us why their new educational module – Rare Disease 101 - should be essential for all healthcare professionals.
Thalassaemia major is a serious, genetic blood disorder. Roanna Maharaj was diagnosed with a severe form of the disease as a baby in the Caribbean. This is her story.
In its second annual clinical trials report launched this week, the ABPI is calling for the research community to work with Government, funders, and the public to tackle issues around diversity and inclusion in research.